Why We Need to Change How We Look for Renal Cell Carcinoma Biomarkers
Proangiogenic or proimmunogenic genomic and transcriptomic signatures in the tumor microenvironment may have predictive value.
Renal Cell Carcinoma
RENAL CELL CARCINOMA ADVISOR
FEATURED CONTENT
-
-
When Patient-Reported Outcomes Could Pose Risks
During a recent conference on quality of life in patients with cancer, FDA-affiliated researchers debunked a notion about biases — but raised some concerns about PROs. -
How to Help Patients With Cancer Find Trustworthy Information Online
Patients may find misinformation on websites or social media forums, but doctors can help by recommending reliable sources. -
Gender Bias in Oncology: Q&A With Dr Narjust Duma
Women are less likely to be introduced by their professional title and most likely to be introduced by first name. -
Study on Veterans Reveals Real-World Survival Outcomes for Targeted Therapies in Advanced Renal Cell Carcinoma
Findings underscore the limited generalizability of clinical trial results to patients in the real world.
VIDEO SERIES
Tivozanib for RCC
Genitourinary Oncology: A Peek Over the Horizon
Immunotherapy of Renal Cell Carcinoma
Targeted Therapies for Renal Cell Carcinoma
Genetics and Heterogeneity
Genetic Predisposition to Kidney Cancers
Personalized Medicines for Kidney Cancers
Drugs in the Pipeline
Resistance to Therapy Among Kidney Cancers
Targeted Therapy
The Role of Neoadjuvant Tx
Sx Options – Ablative Techniques
Sx Options – Lymph Node
Sx Options – Cytoreductive Nephrectomy
TKIs – First-Line Therapy
TKIs – Second-Line Therapy
Biomarkers in RCC
The MET Pathway
Checkpoint Inhibitors
RENAL CELL CARCINOMA NEWS
High-Throughput Multichain Immune Repertoire Sequencing for Prediction of Treatment Response in Renal Cell Carcinoma
Machine-Based CT May Help Identify BAP1 Mutation Status in Clear Cell Renal Cell Carcinoma
RCC With Isolated Lymph Node Metastases Has Poor Prognosis After Surgery
Adjuvant Sorafenib Does Not Improve Survival in Renal Cell Carcinoma
Longer Duration of Steroids May Affect Outcomes During Anti-PD-1 Treatment
Want to read more?
Please login or register first to view this content.
Next post in Renal Cell Carcinoma
